COGT
COGT
NASDAQ · Biotechnology

Cogent Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$34.96
-0.45 (-1.27%)
As of Mar 24, 9:52 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 16 84%
Hold 3 16%
Sell 0 0%
Price Target
Analyst Price Target +140.2% upside
Low Target $51.90
Average Target $83.97
High Target $108.57
Current Price $34.96
Current
$34.96
Target
$83.97
$51.90 $83.97 avg $108.57
Scenario Analysis
Bear Case
$51.90
48.5%
Low target
Base Case
$83.97
+140.2%
Avg target
Bull Case
$108.57
+210.6%
High target
Risk/Reward
4.3x
Highly favorable
Price in Context
52-Week High
$43.73
-20.1% from high
52-Week Low
$3.72
+839.8% from low
50-Day SMA
$37.85
-7.6% vs SMA
200-Day SMA
$20.09
+74.0% vs SMA
RSI (14)
53.0
Neutral
Target vs 52W High
$83.97
+92.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%